Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to improve CPAP treatment compliance of Obstructive Sleep Apnea Syndrome using an integrated telemedicine platform (MyOSA system)


Clinical Trial Description

Obstructive Sleep Apnea (OSA) is defined by the presence of repetitive episodes of upper airways collapse during sleep, leading to nocturnal hypoxemia, sleep fragmentation and daytime sleepiness. When untreated, OSA is a risk factor for arterial hypertension , cardiovascular and cerebrovascular diseases, road accidents and a worse quality of life. The application of a continuous positive airways pressure (CPAP) represents the first line therapy in patients with moderate to severe OSA. CPAP treatment improves daytime sleepiness and oxygen saturation, reduces cardiovascular risk, ameliorates neurobehavioral performance, improves quality of life and reduces road accidents. Despite its demonstrated efficacy, CPAP effectiveness is significantly limited by poor adherence. A closer follow up could improve CPAP adherence but it would take up more work and additional costs for sleep units.

So, on that account, the investigators propose a study to evaluate the effect of adding a telemedicine approach to traditional follow up on CPAP treatment compliance, patients' satisfaction and follow-up costs.

Telemedicine will be provided by an integrated platform composed by a web site (https://www.myosa.net/menu/login.aspx) and a smartphone application.

Methods:

Design: Prospective randomised clinical study. Follow up: 6 months. Participants: 60 patients diagnosed as OSA at St. Maria's Hospital (Sleep Unit) and requiring CPAP treatment.

Randomization: Patients will be randomized into two groups differing in CPAP treatment management (standard care vs. telemedicine). Patients of both groups will be visited in Sleep Unit at 3st and 6th month after starting CPAP treatment. The CPAP machine of both groups will be provided with a modem sending daily information about CPAP treatment compliance and adherence to MyOSA web site (this kind of information will only be actively used during the follow-up in the telemedicine group).

Intervention:

Group 1- Telemedicine Patients will be fitted with a mask , given a CPAP, and instructed on how to use the device. An intelligent software specifically developed for this project will be integrated in the web site. Using patients' baseline data (sociodemographic characteristics, presence of comorbidities, quality of life, sleepiness, pharmacologic treatment, toxic habits), the software will be capable to provide an initial prediction of the expected CPAP compliance at 6 months. Then, the real data about patients' treatment compliance sent on daily base by the CPAP machine will train the software improving the level of confidence of the prediction. Based on the prediction of compliance at six months, the software will provide specific and personalized interventions to modify or maintain this prediction. Interventions will be administered to the patients through a smartphone application connected to the web site and specifically developed for this study (MyOSA-App). Using the mobile-app patients will receive information about their own CPAP compliance and advice on how to improve compliance. All patients will be visited at 3 and 6 months at sleep unit. Patients will be checked about progress and adherence to therapy and any problems with their machine.

Group 2- Standard care Patients will be fitted with a mask and given a CPAP and instructed on how to use the device. Each CPAP machine will be provided with a modem sending daily compliance and adherence information to MyOSA web site but no intervention based on these data is planned in this group. All patients will be visited at 1, 3 and 6 months at sleep unit. Patients will be checked about progress and adherence to therapy and any problems with their machine. Information will be downloaded from their machines (CPAP adherence, applied CPAP pressure, mask leak, and residual respiratory events…). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03116958
Study type Interventional
Source Sociedad Española de Neumología y Cirugía Torácica
Contact
Status Completed
Phase N/A
Start date November 2016
Completion date December 2017

See also
  Status Clinical Trial Phase
Completed NCT02916160 - Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study Phase 4
Active, not recruiting NCT00746928 - Cardiovascular Consequences of Intermittent Hypoxia in Healthy Subjects N/A
Terminated NCT00816829 - Effect of Fenofibrate on Sleep Apnea Syndrome Phase 2
Recruiting NCT00152711 - Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis N/A
Completed NCT02482480 - Comprehensive Management for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT02408172 - Effects of Metoprolol and Amlodipine on Cardiac Remodeling, Arrhythmias and Blood Pressure Variation in Hypertensive Patients With Sleep Apnea Syndrome Phase 2/Phase 3
Terminated NCT01354756 - Validation of Apnea LinkTM for Sleep Apnea Syndrome Screening in a Bariatric Population N/A
Terminated NCT01196845 - Inflammation and Oxidative Stress of Adipose Tissue in Sleep Apnea Syndrome N/A
Terminated NCT02649933 - Detection of Sleep Apnea Syndrome (OSA) in Pregnant Women and Assessment of Impact of OSA on Pregnancy Course N/A
Completed NCT02789696 - Prevalence of Acromegaly in a Diagnostic Consultation for Sleep Apnea Syndrome N/A
Completed NCT01164631 - Pharyngeal Size in Patients With Obstructive Tonsils Under Orthodontic Treatment Phase 4
Completed NCT00317083 - Cough Reflex and Obstructive Sleep Apnea Syndrome N/A
Completed NCT02893865 - Evolution of Oxidative Stress in Coronary Patients With Moderate Sleep Apnea Syndrome After Treatment With Continuous Positive Airway Pressure N/A
Completed NCT02234765 - Management of Patients With Suspected of Sleep Apnea-hypopnea Syndrome From Primary Care N/A
Completed NCT01752556 - Cost-effectiveness of Home Respiratory Polygraphy Phase 3
Completed NCT00001723 - Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases Phase 2
Completed NCT02148432 - Establishment of Ideal IV Sedative Regimen for Successful Fiberoptic Bronchoscopy in Assessing the Site, Severity of Sleep Apnea Syndrome N/A
Completed NCT02657304 - Effect of Early Education on the Observance of CPAP Treatment N/A
Completed NCT02591979 - PASHOS Project: Advanced Platform for Sleep Apnea Syndrome Assessment
Recruiting NCT00936273 - Sleep Apnea and Periodic Breathing N/A